What Diseases Can Brigatinib Treat
When used as monotherapy, brigatinib is specifically indicated for ALK-positive mid-to-late stage or metastatic non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by abnormal alterations in the ALK gene within cancer cells, leading to rapid tumor growth and spread. Through long-term administration, the drug can continuously inhibit tumor progression, and studies have shown that its inhibitory effect is closely related to the dosage (higher doses are associated with more pronounced efficacy).
What Symptoms Can Brigatinib Alleviate
For patients with ALK-positive lung cancer, brigatinib can help alleviate respiratory symptoms caused by the tumor, such as:
Persistent cough (especially chronic cough with no obvious trigger);
Chest pain or pressure (which may result from tumor compression of thoracic tissues);
Dyspnea (commonly observed when the tumor affects pulmonary function).
Are There Other Uses for Brigatinib
Currently, it is unclear whether brigatinib has other therapeutic effects.
Which Drugs Are Commonly Used with Brigatinib
The concomitant use of brigatinib with other medications must strictly follow medical guidance. Since different drugs may interact to affect efficacy or increase the risk of adverse reactions, patients must not adjust their medication regimen on their own. Specific combination therapy regimens must be formulated by a professional physician based on the patient’s individual circumstances.
